McIntyre, Freedman & Flynn Investment Advisers’s Merck MRK Stock Holding History

McIntyre, Freedman & Flynn Investment Advisers’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.85M	Sell	22,154 -7,850	-26%	-$919K	1.71%	19
2026 Q1	$3.61M	Buy	30,004 +147	+0.5%	+$17K	2.05%	16
2025 Q4	$3.14M	Sell	29,857 -2,083	-7%	-$196K	1.97%	16
2025 Q3	$2.68M	Sell	31,940 -249	-0.8%	-$20.5K	1.61%	23
2025 Q2	$2.55M	Buy	32,189 +201	+0.6%	+$16K	1.8%	18
2025 Q1	$2.87M	Buy	31,988 +1	+0%	+$93	2.11%	17
2024 Q4	$3.18M	Buy	31,987 +101	+0.3%	+$10.4K	2.38%	12
2024 Q3	$3.62M	Sell	31,886 -75	-0.2%	-$8.91K	2.58%	10
2024 Q2	$3.96M	Sell	31,961 -29	-0.1%	-$3.74K	2.85%	6
2024 Q1	$4.22M	Sell	31,990 -574	-2%	-$70.8K	3.07%	6
2023 Q4	$3.55M	Buy	32,564 +1	+0%	+$104	2.84%	6
2023 Q3	$3.35M	Sell	32,563 -99	-0.3%	-$10.7K	2.83%	6
2023 Q2	$3.77M	Sell	32,662 -2,000	-6%	-$227K	3.22%	5
2023 Q1	$3.69M	Buy	34,662 +1	+0%	+$108	3.13%	6
2022 Q4	$3.85M	Buy	+34,661	New	+$3.54M	3.18%	7

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

McIntyre, Freedman & Flynn Investment Advisers's MRK Position: Q2 2026 in Review

McIntyre, Freedman & Flynn Investment Advisers reduced its Merck (MRK) stake by 26% in Q2 2026, selling an estimated $919K and leaving 22,154 shares worth $2.85M. The position accounts for 1.71% of the portfolio, ranked #19.

McIntyre, Freedman & Flynn Investment Advisers first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.22M in Q1 2024. 3,099 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

McIntyre, Freedman & Flynn Investment Advisers held 22,154 shares of Merck worth $2.85M as of Q2 2026.
McIntyre, Freedman & Flynn Investment Advisers sold 7,850 Merck shares in Q2 2026, an estimated $919K.
Merck made up 1.71% of McIntyre, Freedman & Flynn Investment Advisers's portfolio in Q2 2026, its #19 holding.
McIntyre, Freedman & Flynn Investment Advisers first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
McIntyre, Freedman & Flynn Investment Advisers's Merck position peaked at $4.22M in Q1 2024.
3,099 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on McIntyre, Freedman & Flynn Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.